Clinical Trials in Ohio

Are you looking to enroll in a clinical trial in Ohio? With new trials like "Thoraflex™ Hybrid IDE Study" and "Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma", the Buckeye State has established itself as a great location for clinical research studies, particularly in cities like Cincinnati and Cleveland.

While some individuals are looking for paid clinical trials, others want to help advance dermatology and urology clinical research in Ohio. To begin your search for Ohio clinical trials, use the form on the right.

Use our guide to learn which trials are right for you!


We've found
9,838
clinical trials in
Ohio

Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Centerville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Delaware, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Greenville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Greenville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Kettering, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Lancaster, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Maumee, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Springfield, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Toledo, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wooster, OH
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Biliary Atresia Clinical Trial
Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia
Status: Enrolling, Phase
Updated: 3/5/2018
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Centerville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Franklin, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Greenville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Lancaster, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Marion, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Troy, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Westerville, OH
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma Clinical Trial
Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Mentor, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Long Term Follow Up for CTSN Mitral Valve Repair Studies
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Rotator Cuff Tear Clinical Trial
Rotator Cuff Failure With Continuity
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Early ART to Limit Infection and Establishment of Reservoir
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Heart Failure Clinical Trial
Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Lumbar Spinal Stenosis Clinical Trial
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lumbar Spinal Stenosis Clinical Trial
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lumbar Spinal Stenosis Clinical Trial
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Clinical Trial
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Clinical Trial
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
EDS in Ataxia Telangiectasia Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Lennox-Gastaut Syndrome (LGS) Clinical Trial
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Epilepsy Clinical Trial
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Akron, OH
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Dayton, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Rheumatology Clinical Trial
Subchondroplasty® Knee RCT
Status: Enrolling
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Barberton, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Belpre, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Centerville, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Dayton, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Findlay, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Greenville, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Marietta, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Mount Vernon, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Beachwood, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Belpre, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Chillicothe, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Delaware, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fairfield, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Findlay, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Findlay, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Kettering, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Marietta, OH
Click here to add this to my saved trials
Orthopedics / Podiatry Clinical Trial
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Endocrinology Clinical Trial
Diabetes: Functional Medicine Approach vs. Usual Care
Status: Enrolling
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Amyloidosis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Centerville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Findlay, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Greenville, OH
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Elyria, OH
Click here to add this to my saved trials
Pediatric Heart Failure Clinical Trial
Pumps for Kids, Infants, and Neonates
Status: Enrolling
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Patients With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Canton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
1 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 98
View Clinical Trial Facilties in Ohio